Target-specific oral anticoagulants: should we switch from warfarin? - Wikidata - wikimedia - TriplyDB

Target-specific oral anticoagulants: should we switch from warfarin?

Target-specific oral anticoagulants: should we switch from warfarin?

http://www.wikidata.org/entity/Q35758778

about

What's New in Anticoagulation.Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: a retrospective observational study in Southern Italy

P2860

Q40517815-2CEB07CD-8DD7-47BD-A731-9C8EAE5BA69C Q57817732-571A6C4E-09FA-4010-B570-04D4249E8DE6

P2860

Target-specific oral anticoagulants: should we switch from warfarin?

http://www.wikidata.org/entity/Q35758778

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Target-specific oral anticoagulants: should we switch from warfarin?

@ast

Target-specific oral anticoagulants: should we switch from warfarin?

@en

type

label

Target-specific oral anticoagulants: should we switch from warfarin?

@ast

Target-specific oral anticoagulants: should we switch from warfarin?

@en

prefLabel

Target-specific oral anticoagulants: should we switch from warfarin?

@ast

Target-specific oral anticoagulants: should we switch from warfarin?

@en

P1433

Q35758778-17E86A53-F031-4664-B28D-23E8EE8E9342

P1476

Q35758778-FABF5D96-D732-4E4C-8525-63E2E9A2FFCF

P2093

Q35758778-788AC69F-8D8C-475E-8CE1-0B8A1C45EA6D

Q35758778-8FA866E7-53BB-46BB-880B-B6FBBFFE4BEF

P2860

Q35758778-175CE04A-4CC1-4ABF-B966-97FD77D487F3

Q35758778-29452EC0-EA83-41D2-9F55-324D480667A4

Q35758778-2B9AD133-7958-40BC-8A82-21E8E2B78CA1

Q35758778-93964224-9C2C-4624-BC57-71A5C968F5B9

Q35758778-9650AEBA-C7F6-4F87-9A77-FC7E9AA34721

Q35758778-A54909F8-5932-41D0-ADB5-7DCC3171A4F8

Q35758778-A96ECAFA-0AF8-494C-8C90-AF73E586CF1E

Q35758778-CF66034E-2BE8-46A6-B53F-62D62FE3A65A

Q35758778-EB808BEF-235C-4BBE-B46A-DC848F48113B

Q35758778-F517C069-D874-42F0-83F7-7CF85991D347

P304

Q35758778-14D1CE7D-CF17-41A8-8105-F9201D0B347E

P31

Q35758778-45C84075-8962-445B-ABE1-F445A3FB9E97

P356

Q35758778-4037ED14-0304-4B46-B6C0-CCE950033409

P433

Q35758778-AC73C90C-9D06-42E9-B4F0-EFF5D6A7703F

P478

Q35758778-74AACB59-AD01-419F-9E58-D43039894038

P577

Q35758778-5AA9C8EC-8D86-4CA2-A10D-04D27FDFD305

P698

Q35758778-CA593253-8A6A-481C-8286-147DF6E66C61

P921

Q35758778-D0FE4DD0-E217-45AC-B527-FF1917B6FC52

P932

Q35758778-70FEAA86-B062-440F-A125-09EB1F1EF23D

P356

P1433

Texas Heart Institute Journal

P1476

Target-specific oral anticoagulants: should we switch from warfarin?

@en

P2093

Mohammad Saeed

http://www.w3.org/2001/XMLSchema#string

Payam Safavi-Naeini

http://www.w3.org/2001/XMLSchema#string

P2860

Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentrates

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD.

New oral anticoagulants for atrial fibrillation: are they worth the risk?

Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.

Transitioning to and from the novel oral anticoagulants: a management strategy for clinicians.

P304

229-233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14503/THIJ-15-5065

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26175634

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

4473615

http://www.w3.org/2001/XMLSchema#string